Barclays Maintains Overweight on Nutrien, Lowers Price Target to $70
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Benjamin Theurer maintains an Overweight rating on Nutrien (NYSE:NTR) and lowers the price target from $80 to $70.
June 01, 2023 | 11:20 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Barclays maintains an Overweight rating on Nutrien (NYSE:NTR) and lowers the price target from $80 to $70.
The news of Barclays maintaining an Overweight rating on Nutrien indicates a positive outlook for the company. However, the lowering of the price target from $80 to $70 suggests a more conservative valuation. This mixed signal may result in a neutral short-term impact on Nutrien's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100